ATE299948T1 - Tripeptidylpeptidase-inhibitoren - Google Patents

Tripeptidylpeptidase-inhibitoren

Info

Publication number
ATE299948T1
ATE299948T1 AT96916181T AT96916181T ATE299948T1 AT E299948 T1 ATE299948 T1 AT E299948T1 AT 96916181 T AT96916181 T AT 96916181T AT 96916181 T AT96916181 T AT 96916181T AT E299948 T1 ATE299948 T1 AT E299948T1
Authority
AT
Austria
Prior art keywords
tripeptidylpeptidase
inhibitors
formulawherein
cholecystokinin
hydrates
Prior art date
Application number
AT96916181T
Other languages
English (en)
Inventor
Christiane Rose
Froylan Vargas
Pierre Bourgeat
Jean-Charles Schwartz
Paul Beaumont Bishop
Ramesh Babarao Bambal
Charon Robin Ganellin
Bertrand Leblond
Andrew N J Moore
Suzanne Chan
Zhao Lihua
Original Assignee
Inst Nat Sante Rech Med
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Bioprojet Soc Civ filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE299948T1 publication Critical patent/ATE299948T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
AT96916181T 1995-05-09 1996-05-09 Tripeptidylpeptidase-inhibitoren ATE299948T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9505489A FR2733995B1 (fr) 1995-05-09 1995-05-09 Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments
PCT/FR1996/000700 WO1996035805A2 (fr) 1995-05-09 1996-05-09 Inhibiteurs de tripeptidylpeptidases

Publications (1)

Publication Number Publication Date
ATE299948T1 true ATE299948T1 (de) 2005-08-15

Family

ID=9478806

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916181T ATE299948T1 (de) 1995-05-09 1996-05-09 Tripeptidylpeptidase-inhibitoren

Country Status (11)

Country Link
US (2) US6403561B1 (de)
EP (1) EP0828851B1 (de)
JP (1) JPH11510684A (de)
AT (1) ATE299948T1 (de)
CA (1) CA2221035A1 (de)
DE (1) DE69634955T2 (de)
DK (1) DK0828851T3 (de)
ES (1) ES2244969T3 (de)
FR (1) FR2733995B1 (de)
PT (1) PT828851E (de)
WO (1) WO1996035805A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733995B1 (fr) * 1995-05-09 1997-07-25 Inst Nat Sante Rech Med Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments
WO1999033801A1 (en) * 1997-12-23 1999-07-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Tripeptidyl peptidase inhibitors
EP1147214B1 (de) 1999-01-13 2011-01-05 The Research Foundation Of State University Of New York Neues verfahren zum erschaffen von proteinkinase-inhibitoren
WO2001081306A2 (en) * 2000-04-19 2001-11-01 Eli Lilly And Company Azide cyclization-based synthesis and intermediates for spla2 inhibitors
SK6282003A3 (en) 2000-10-30 2004-02-03 Janssen Pharmaceutica Nv Tripeptidyl peptidase inhibitors
WO2003035621A1 (en) * 2001-10-22 2003-05-01 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
US7005445B2 (en) 2001-10-22 2006-02-28 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors and methods for designing them
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
US20040097422A1 (en) * 2002-06-14 2004-05-20 Karl Munger Methods of use for tripeptidyl peptidase II inhibitors as anticancer agents
US7838542B2 (en) 2006-06-29 2010-11-23 Kinex Pharmaceuticals, Llc Bicyclic compositions and methods for modulating a kinase cascade
US9403768B2 (en) 2012-10-11 2016-08-02 Hoffmann-La Roche Inc. Indolines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH626872A5 (de) * 1976-06-21 1981-12-15 Hoffmann La Roche
PH14141A (en) * 1976-06-25 1981-03-05 Hoffmann La Roche Pharmaceutical composition containing dipeptide derivatives
HU180925B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem
CS226907B1 (en) * 1981-08-07 1984-04-16 Kasafirek Evzen Alkylamides of carboxyalkanoylpeptides
AT389517B (de) * 1987-10-08 1989-12-27 Hoechst Ag Chromophore peptide, verfahren zu ihrer herstellung und ihre verwendung zum nachweis der peptidylglycin-alpha-amidierenden monooxygenase
US5159060A (en) * 1988-05-27 1992-10-27 Mayo Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
ATE349461T1 (de) * 1991-10-22 2007-01-15 New England Medical Center Inc Inhibitoren der dipeptidyl-aminopeptidase vom typ iv
FR2733995B1 (fr) * 1995-05-09 1997-07-25 Inst Nat Sante Rech Med Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments

Also Published As

Publication number Publication date
EP0828851A2 (de) 1998-03-18
CA2221035A1 (fr) 1996-11-14
EP0828851B1 (de) 2005-07-20
ES2244969T3 (es) 2005-12-16
US6403561B1 (en) 2002-06-11
DE69634955T2 (de) 2006-05-24
DE69634955D1 (de) 2005-08-25
JPH11510684A (ja) 1999-09-21
PT828851E (pt) 2005-11-30
DK0828851T3 (da) 2005-10-24
WO1996035805A2 (fr) 1996-11-14
FR2733995B1 (fr) 1997-07-25
WO1996035805A3 (fr) 1997-01-30
US20030027743A1 (en) 2003-02-06
FR2733995A1 (fr) 1996-11-15

Similar Documents

Publication Publication Date Title
MX9302011A (es) Derivados de indol.
PT946507E (pt) Compostos de pirrolilo substituidos para o tratamento da inflamacao
ES2116436T5 (es) Carbamatos y agentes fitosanitarios que contienen estos.
DE69325249D1 (de) Behandlung von unterirdischen Lagerstätten mit Zellulose- und Guarderivaten
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
SE9103612D0 (sv) New peptide derivatives
NO942994D0 (no) Aminoacetylmercaptoacetylamidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
ATE299948T1 (de) Tripeptidylpeptidase-inhibitoren
BG102918A (en) Biphenylsulphanomide inhibitors of the matrix metalloproteinase
UA66793C2 (uk) Лептин як стримувач швидкого збільшення пухлини клітини
DE69808099D1 (de) Substituierte 6-alkylphenanthridine
MX9702035A (es) Inhibidores de 5-alfa reductasa.
TR199801665T2 (xx) Makular �demin engellenmesi i�in karbonik anhidraz inhibit�rlerinin kullan�m�.
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
NO911999L (no) Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp.
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
FI946156A (fi) Luun uudistumiseen vaikuttavien kasvutekijöiden kohdistettu anto
DE59709922D1 (de) Pflaster zur transdermalen anwendung von pergolid
ES2060405T3 (es) Derivado de la melatonina que tiene actividad terapeutica en dermatologia.
FI954367A0 (fi) Substituoitujen alkyylinitraattien käyttö patologisesti kohonneen intraokulaarisen paineen hoitamiseksi
EE9700350A (et) COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod
AP9701148A0 (en) Dimesylate salts of neuropeptide Y ligands.
AR005866A1 (es) Composicion farmaceutica antioxidante
EA199900174A1 (ru) Способ лечения биполярного расстройства
ATE306269T1 (de) Behandlung der exzessiven aggressivität mit olanzapine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0828851

Country of ref document: EP

REN Ceased due to non-payment of the annual fee